MCK 投資分析

看多重點:

  • 價值≥4
  • 股利≥2

分析結論

價值面評分較低,股利評分中等,若有更好的價值投資標的,可以部分換股操作

MCK 近期報酬表現

-0.09%

Mckesson corporation

1.41%

同產業平均

0.09%

S&P500

與 MCK 同產業的標的表現

  • COR Cencora inc
    價值 4 分趨勢 2 分波段 1 分籌碼 3 分股利 4 分
    查看更多

MCK 公司資訊

McKesson Corporation is a provider of diversified healthcare services. The Company is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies. Its International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada.

MCK 股價